COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,556 Articles (22,400 medRxiv, 8,156 bioRxiv)

Most recent first Previous |  Page 2853: Articles 28521-28530  | Next

Persistent viral shedding of SARS-CoV-2 in faeces - a rapid review
Gupta, S., Parker, J., Dolwani, S., Smits, S., Underwood, J.
10.1101/2020.04.17.20069526 — Posted: 2020-04-22
Evidence for probable aerosol transmission of SARS-CoV-2 in a poorly ventilated restaurant
Li, Y., Qian, H., Hang, J., Chen, X., Hong, L., Liang, P., Li, J., Xiao, S., Wei, J., Liu, L., Kang, M.
10.1101/2020.04.16.20067728 — Posted: 2020-04-22 Discussion: Onsite | Offsite
Estimating the impact of COVID-19 control measures using a Bayesian model of physical distancing
Anderson, S. C., Edwards, A. M., Yerlanov, M., Mulberry, N., Stockdale, J., Iyaniwura, S. A., Falcao, R. C., Otterstatter, M. C., Irvine, M. A., Janjua, N. Z., Coombs, D., Colijn, C.
10.1101/2020.04.17.20070086 — Posted: 2020-04-22 Discussion: Onsite
COVID-19 Outbreak Prediction with Machine Learning
Ardabili, S. F., MOSAVI, A., Ghamisi, P., Ferdinand, F., Varkonyi-Koczy, A. R., Reuter, U., Rabczuk, T., Atkinson, P. M.
10.1101/2020.04.17.20070094 — Posted: 2020-04-22
Assessment of Fabric Masks as Alternatives to Standard Surgical Masks in Terms of Particle Filtration Efficiency
Mueller, A. V., Fernandez, L. A.
10.1101/2020.04.17.20069567 — Posted: 2020-04-22 Discussion: Onsite
Social Distancing and Personal Protective Measures Decrease Influenza Morbidity and Mortality
Young, G. M., Peng, X., Rebaza, A., Bermejo, S., Chang, D., Sharma, L., Dela Cruz, C.
10.1101/2020.04.17.20070102 — Posted: 2020-04-22
An ecological study of socioeconomic predictors in detection of COVID-19 cases across neighborhoods in New York City
Whittle, R. S., Diaz-Artiles, A.
10.1101/2020.04.17.20069823 — Posted: 2020-04-22
Surveying Tenants of Permanent Supportive Housing in Skid Row about COVID-19
Henwood, B. F., Redline, B., Lahey, J.
10.1101/2020.04.17.20070052 — Posted: 2020-04-22
CAN-NPI: A Curated Open Dataset of Canadian Non-Pharmaceutical Interventions in Response to the Global COVID-19 Pandemic
McCoy, L. G., Smith, J., Anchuri, K., Berry, I., Pineda, J., Harish, V., Lam, A. T., Yi, S. E., Hu, S., Canadian Open Data Working Group: Non-Pharmaceutical Interventions, , Fine, B.
10.1101/2020.04.17.20068460 — Posted: 2020-04-22
Prediction of Coronavirus Disease (covid-19) Evolution in USA with the Model Based on the Eyring Rate Process Theory and Free Volume Concept
Hao, T.
10.1101/2020.04.16.20068692 — Posted: 2020-04-22

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).